Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Pegylated Interferon Plus Ribavirin in Hepatitis C IDUs
NCT00203606Phase 4Completed
- Sponsor
- University of Calgary
- Start
- Jan 2004
- Primary completion
- Jan 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by University of Calgary. Started Jan 2004; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00203606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203606.